MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 2 filers reported holding MERSANA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $61,352 | +151.9% | 48,309 | +552.6% | 0.00% | +100.0% |
Q2 2023 | $24,355 | +25269.8% | 7,403 | -68.4% | 0.00% | -66.7% |
Q1 2023 | $96 | -55.3% | 23,450 | -36.1% | 0.00% | -66.7% |
Q4 2022 | $215 | -99.9% | 36,698 | +0.8% | 0.01% | +125.0% |
Q3 2022 | $246,000 | +530.8% | 36,410 | +328.8% | 0.00% | +300.0% |
Q2 2022 | $39,000 | +14.7% | 8,492 | +0.8% | 0.00% | – |
Q1 2022 | $34,000 | -72.6% | 8,425 | -57.5% | 0.00% | -100.0% |
Q4 2021 | $124,000 | +51.2% | 19,846 | +128.3% | 0.00% | 0.0% |
Q3 2021 | $82,000 | +3.8% | 8,693 | +49.2% | 0.00% | 0.0% |
Q2 2021 | $79,000 | -42.3% | 5,825 | -31.5% | 0.00% | 0.0% |
Q1 2021 | $137,000 | +661.1% | 8,501 | +1153.8% | 0.00% | +100.0% |
Q4 2020 | $18,000 | -85.7% | 678 | -90.0% | 0.00% | 0.0% |
Q3 2020 | $126,000 | -43.5% | 6,791 | -28.6% | 0.00% | -88.9% |
Q2 2020 | $223,000 | +5475.0% | 9,512 | +1128.9% | 0.01% | – |
Q4 2019 | $4,000 | -66.7% | 774 | -89.8% | 0.00% | -100.0% |
Q3 2019 | $12,000 | -14.3% | 7,568 | +125.9% | 0.00% | 0.0% |
Q2 2019 | $14,000 | +75.0% | 3,350 | +116.1% | 0.00% | – |
Q1 2019 | $8,000 | -82.2% | 1,550 | -85.8% | 0.00% | -100.0% |
Q4 2018 | $45,000 | +18.4% | 10,929 | +189.1% | 0.00% | 0.0% |
Q3 2018 | $38,000 | -2.6% | 3,781 | +72.6% | 0.00% | +50.0% |
Q2 2018 | $39,000 | +680.0% | 2,190 | +622.8% | 0.00% | – |
Q3 2017 | $5,000 | – | 303 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |